Loading organizations...
Zus Health provides a shared health data platform accelerating healthcare data interoperability for digital health. Its core Zus Aggregated Profile (ZAP) unifies patient information from fragmented sources. The platform leverages a HIPAA-compliant, FHIR-native architecture, using a Universal Patient Index for identity matching, and standardizing clinical data.
Jonathan Bush, co-founder of athenahealth, established Zus Health, believing pervasive data fragmentation impedes effective modern healthcare. His insight was to build foundational data infrastructure, allowing digital health innovators to deploy solutions without re-engineering core interoperability. This origin aims to transform disconnected health records into cohesive, actionable resources for providers.
Zus Health serves healthcare developers, clinicians, and operators, empowering organizations to improve patient and care team experiences and optimize workflows. The platform enhances efficiencies in patient intake and comprehensive care planning via accessible patient histories. Its vision is to foster a fluid “health data grid,” driving data-powered innovation and cultivating a patient-centric ecosystem.
Zus Health has raised $74.0M across 2 funding rounds.
Zus Health has raised $74.0M in total across 2 funding rounds.
Zus Health has raised $74.0M across 2 funding rounds. Most recently, it raised $40.0M Series A in March 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2023 | $40M Series A | — | Andreessen Horowitz, JAZZ Venture Partners, Primary Venture Partners, Richard Branson, A16z Scout Fund, F Prime Capital, Maverick Ventures | Announced |
| Jun 1, 2021 | $34M Series A | Julie YOO | Andreessen Horowitz, Primary Venture Partners, Richard Branson, F Prime Capital, Martin Ventures, Maverick Ventures, Oxeon Investments, Rock Health | Announced |
Zus Health has raised $74.0M in total across 2 funding rounds.
Zus Health's investors include Andreessen Horowitz, Jazz Venture Partners, Primary Venture Partners, Richard Branson, F-Prime Capital, Maverick Ventures, Julie Yoo, Martin Ventures, Oxeon Investments, Rock Health.
Zus Health is a Boston-based health tech company founded in 2020 that builds a shared health data platform to accelerate healthcare data interoperability.[1][4] Its core product, the Zus Aggregated Profile (ZAP), aggregates and unifies patient data—including demographics, conditions, medications, diagnostics, encounters, notes, documents, allergies, immunizations, and care team details—delivering a comprehensive, de-duplicated view accessible at the point of care via APIs, embedded components, and direct EHR integrations.[1][3][7] Zus serves healthcare organizations, clinicians, health tech developers, and information exchanges, solving the problem of fragmented, siloed data that hinders patient outcomes, care team efficiency, and innovation by providing easy-to-use, intelligently refreshed patient insights.[2][3][5] The company demonstrates strong growth momentum, with recent announcements of new clients, AI-powered innovations like human-readable narrative summaries and risk-suspecting engines, and seamless integrations reported by early adopters as of February 2025.[1]
Zus Health, formerly known as Zeus Healthcare Technologies, was founded in 2020 in Boston, Massachusetts, amid growing frustrations with healthcare's data silos.[1] Key leadership includes CEO Jonathan Bush, a serial entrepreneur with prior experience at athenahealth, who has emphasized rewiring healthcare for speed and clinical truth.[1] The idea emerged from the need to unify disconnected patient data into actionable records, enabling builders to innovate without rebuilding infrastructure—catalyzing "healthcare’s greatest inventors" by maximizing patient insights.[2][6] Early traction built around the Zus Grid and ZAP, with pivotal expansions into AI-driven tools and partnerships like Elation Health, positioning Zus as a foundational platform for value-based care.[1][3]
Zus stands out in health tech through these key strengths:
Zus rides the wave of healthcare data interoperability and AI-driven value-based care, addressing chronic fragmentation across EHRs and systems that stalls innovation and outcomes.[1][4][5] Timing is ideal amid regulatory pushes like TEFCA and rising demand for real-time insights in a post-pandemic era prioritizing efficiency and prevention.[1] Market forces favoring Zus include explosive growth in health tech builders needing scalable data platforms, plus AI's ability to surface risks and gaps beyond traditional settings.[1][2] By enabling seamless data sharing, Zus influences the ecosystem as infrastructure for developers, clinicians, and exchanges—unlocking business value, reducing hospitalizations, and fostering a "clinical truth" standard that accelerates broader transformation.[1][3][5]
Zus Health is poised for rapid scaling with its AI suite in testing and client wins signaling product-market fit in a $100B+ interoperability market.[1] Upcoming trends like advanced care gap identification and expanded AI will shape its path, potentially dominating as health systems shift to proactive, data-unified models.[1] Its influence could evolve from enabler to category leader, rewiring care delivery as Bush envisions—starting with aggregated profiles that humanize data for inventors building the future.[1][2] This positions Zus as essential infrastructure in an increasingly connected health ecosystem.
